Please login to the form below
1
Revenue 2017Humira
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.
Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
In one of these studies – FINCH 1 – the JAK inhibitor was compared to AbbVie’s TNF antibody Humira (adalimumab) or placebo – given on top of methotrexate – in patients with ... of Humira which is given by injection.
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
Otezla fits right into Amgen’s existing psoriasis and anti-inflammatory product range, which includes Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s Humira (adalimumab) which is approved and already
Cortellis Drugs to Watch in 2020 report
The drug must leverage its competitive profile as it will face significant competition from entrenched biological agents (and biosimilar versions), including Humira and Enbrel, as well as direct competition from other
Pharma funding and M&A in 2020
a cool $63bn (which was also notable for putting the world’s best-selling drug Humira under the same roof as Botox).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
-
Publications Director
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Manager
-
Salary TBC
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Sanofi’s C1s inhibitor sutimlimab hits the mark in late-stage CAD study
- Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
- Your clinical trial participants are precious, so treat them as such
- Live Webinar: Helping Patients Become Active Participants in Their Own Care
- Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
- Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3
- The power of communication: Engaging diverse groups in healthcare
- US trial data shows Novavax’s COVID-19 vaccine is 90% effective
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- Diversity and inclusion in clinical trials
- Nicky Hutchens appointed as deputy managing director at Four Health
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- Lucid Group acquires US-based strategic brand consultants DiD
- Novo Nordisk says Victoza outperforms SGLT2 inhibitors
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
- Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
- The power of communication: Engaging diverse groups in healthcare
- Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
- Building the hospital of the future
- Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
